You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1372 TriTCE Co-Stim: a novel trispecific T cell engager platform, with integrated CD28 costimulation, engineered to widen the therapeutic window for treatment of poorly infiltrated tumors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1372 TriTCE Co-Stim: a novel trispecific T cell engager platform, with integrated CD28 costimulation, engineered to widen the therapeutic window for treatment of poorly infiltrated tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023208034
Dec 20235805
Jan 20245104
Feb 20245206
Mar 20249007
Apr 2024102011
May 2024230018
Jun 202496017
Jul 2024116015
Aug 202464018
Sep 202476010
Oct 2024126040
Nov 2024191049
Dec 2024152024
Jan 2025116025
Feb 20253809
Mar 2025009
Apr 20251011
May 20250020
Jun 20250010
Total17670342